CLBT Relative Valuation
CLBT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CLBT is overvalued; if below, it's undervalued.
Historical Valuation
Cellebrite DI Ltd (CLBT) is now in the Fair zone, suggesting that its current forward PE ratio of 34.20 is considered Fairly compared with the five-year average of 46.49. The fair price of Cellebrite DI Ltd (CLBT) is between 15.09 to 35.09 according to relative valuation methord.
Relative Value
Fair Zone
15.09-35.09
Current Price：18.00
Fair
34.58
PE
1Y
3Y
5Y
Trailing
Forward
26.96
EV/EBITDA
Cellebrite DI Ltd. (CLBT) has a current EV/EBITDA of 26.96. The 5-year average EV/EBITDA is 26.48. The thresholds are as follows: Strongly Undervalued below 1.05, Undervalued between 1.05 and 13.76, Fairly Valued between 39.19 and 13.76, Overvalued between 39.19 and 51.90, and Strongly Overvalued above 51.90. The current Forward EV/EBITDA of 26.96 falls within the Historic Trend Line -Fairly Valued range.
28.81
EV/EBIT
Cellebrite DI Ltd. (CLBT) has a current EV/EBIT of 28.81. The 5-year average EV/EBIT is 31.93. The thresholds are as follows: Strongly Undervalued below -4.24, Undervalued between -4.24 and 13.85, Fairly Valued between 50.02 and 13.85, Overvalued between 50.02 and 68.10, and Strongly Overvalued above 68.10. The current Forward EV/EBIT of 28.81 falls within the Historic Trend Line -Fairly Valued range.
8.35
PS
Cellebrite DI Ltd. (CLBT) has a current PS of 8.35. The 5-year average PS is 5.32. The thresholds are as follows: Strongly Undervalued below 0.35, Undervalued between 0.35 and 2.83, Fairly Valued between 7.81 and 2.83, Overvalued between 7.81 and 10.30, and Strongly Overvalued above 10.30. The current Forward PS of 8.35 falls within the Overvalued range.
21.16
P/OCF
Cellebrite DI Ltd. (CLBT) has a current P/OCF of 21.16. The 5-year average P/OCF is 24.55. The thresholds are as follows: Strongly Undervalued below 4.86, Undervalued between 4.86 and 14.71, Fairly Valued between 34.39 and 14.71, Overvalued between 34.39 and 44.24, and Strongly Overvalued above 44.24. The current Forward P/OCF of 21.16 falls within the Historic Trend Line -Fairly Valued range.
26.87
P/FCF
Cellebrite DI Ltd. (CLBT) has a current P/FCF of 26.87. The 5-year average P/FCF is 26.20. The thresholds are as follows: Strongly Undervalued below 3.47, Undervalued between 3.47 and 14.84, Fairly Valued between 37.57 and 14.84, Overvalued between 37.57 and 48.94, and Strongly Overvalued above 48.94. The current Forward P/FCF of 26.87 falls within the Historic Trend Line -Fairly Valued range.
Cellebrite DI Ltd (CLBT) has a current Price-to-Book (P/B) ratio of 9.79. Compared to its 3-year average P/B ratio of 7.43 , the current P/B ratio is approximately 31.74% higher. Relative to its 5-year average P/B ratio of 4.92, the current P/B ratio is about 99.10% higher. Cellebrite DI Ltd (CLBT) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 3.45%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 3.58% , the current FCF yield is about -100.00% lower.
9.90
P/B
Median3y
7.43
Median5y
4.92
3.19
FCF Yield
Median3y
3.45
Median5y
3.58
Competitors Valuation Multiple
The average P/S ratio for CLBT's competitors is 5.33, providing a benchmark for relative valuation. Cellebrite DI Ltd Corp (CLBT) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 17.94%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of CLBT decreased by 17.39% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 33.62 to 58.15.
The secondary factor is the Revenue Growth, contributed 17.94%to the performance.
Overall, the performance of CLBT in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Cellebrite DI Ltd (CLBT) currently overvalued or undervalued?
What is Cellebrite DI Ltd (CLBT) fair value?
How does CLBT's valuation metrics compare to the industry average?
What is the current P/B ratio for Cellebrite DI Ltd (CLBT) as of Dec 05 2025?
What is the current FCF Yield for Cellebrite DI Ltd (CLBT) as of Dec 05 2025?
What is the current Forward P/E ratio for Cellebrite DI Ltd (CLBT) as of Dec 05 2025?